Literature DB >> 23877104

Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.

Takashi Okura1, Sayaka Kato, Yoshiharu Deguchi.   

Abstract

The aim of this study was to examine whether organic cation/carnitine transporter 2 (OCTN2/SLC22A5) plays a role in the human blood-brain barrier (BBB) by evaluating its functional activity in human brain endothelial cells (hCMEC/D3), which are considered to be a model of the BBB. The uptake of [(3)H]L-carnitine by hCMEC/D3 cells was time-, extracellular sodium- and concentration-dependent, with a Km value of 15.7 µM. These results are consistent with the properties of OCTN2-mediated L-carnitine transport. hCMEC/D3 cells showed relatively high expression of OCTN2 mRNA, and this expression was effectively decreased at 24-72 h after lipofection of cells with OCTN2 siRNA under optimized conditions. [(3)H]L-Carnitine uptake was dramatically suppressed by silencing of the OCTN2 gene. The inhibitory effect of OCTN2 gene silencing was similar to that of an excess amount of unlabeled L-carnitine. These results indicate that OCTN2 is involved in L-carnitine transport at the human BBB.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23877104     DOI: 10.2133/dmpk.dmpk-13-rg-058

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  9 in total

1.  The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family.

Authors:  Joao N Dos Santos Pereira; Sina Tadjerpisheh; Manar Abu Abed; Ali R Saadatmand; Babette Weksler; Ignacio A Romero; Pierre-Olivier Couraud; Jürgen Brockmöller; Mladen V Tzvetkov
Journal:  AAPS J       Date:  2014-08-26       Impact factor: 4.009

Review 2.  Solute Carriers in the Blood-Brain Barier: Safety in Abundance.

Authors:  Katarzyna A Nałęcz
Journal:  Neurochem Res       Date:  2016-08-09       Impact factor: 3.996

Review 3.  Brain carnitine deficiency causes nonsyndromic autism with an extreme male bias: A hypothesis.

Authors:  Arthur L Beaudet
Journal:  Bioessays       Date:  2017-07-13       Impact factor: 4.345

Review 4.  The role of SLC transporters for brain health and disease.

Authors:  Yen T K Nguyen; Hoa T T Ha; Tra H Nguyen; Long N Nguyen
Journal:  Cell Mol Life Sci       Date:  2021-12-31       Impact factor: 9.261

Review 5.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

6.  Differences in Cerebral Distribution between Imipramine and Paroxetine via Membrane Transporters at the Rat Blood-Brain Barrier.

Authors:  Shin-Ichi Akanuma; Myeongrae Han; Yuka Murayama; Yoshiyuki Kubo; Ken-Ichi Hosoya
Journal:  Pharm Res       Date:  2022-02-02       Impact factor: 4.200

7.  Reduced L-carnitine transport in aortic endothelial cells from spontaneously hypertensive rats.

Authors:  Rocío Salsoso; Enrique Guzmán-Gutiérrez; Pablo Arroyo; Carlos Salomón; Sonia Zambrano; María Victoria Ruiz-Armenta; Antonio Jesús Blanca; Fabián Pardo; Andrea Leiva; Alfonso Mate; Luis Sobrevia; Carmen María Vázquez
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

8.  Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.

Authors:  Yu Takahashi; Tomohiro Nishimura; Kei Higuchi; Saki Noguchi; Yuma Tega; Toshiki Kurosawa; Yoshiharu Deguchi; Masatoshi Tomi
Journal:  Pharm Res       Date:  2018-10-29       Impact factor: 4.200

Review 9.  In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration.

Authors:  Marialena Chrysanthou; Ignacio Miro Estruch; Ivonne M C M Rietjens; Harry J Wichers; Tamara Hoppenbrouwers
Journal:  Nutrients       Date:  2022-01-15       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.